Skip to content
2000
Volume 18, Issue 30
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

The protein-protein interaction (PPI) between p53 and its negative regulator MDM2 comprises one of the most important and intensely studied PPI's involved in preventing the initiation of cancer. The interaction between p53 and MDM2 is conformation-based and is tightly regulated on multiple levels. Due to the Angstrom level structural insight there is a reasonable understanding of the structural requirements needed for a molecule to bind to MDM2 and successfully inhibit the p53/MDM2 interaction. The current review summarizes the binding characteristics of the different disclosed small molecules for inhibition of MDM2 with a co-crystal structure. Synthetic access to these compounds as well as their derivatives are described in detail.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161212802651580
2012-10-01
2025-05-08
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161212802651580
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test